As insulin in the brain contributes to the control of nutrient homeostasis, cognition, memory, as well as neuromodulatory and neuroprotective effects, alterations of these functional activities may contribute to the manifestation of clinical entities, including central insulin resistance and T2DM [67]. The gene discussed is INS; the disease is type 2 diabetes mellitus.